Leica Biosystems Partners with L7 Informatics for Future Solutions
Leica Biosystems has joined forces with L7 Informatics to enhance the operational efficiency in pathology labs. This collaboration aims to create a unified, AI-ready platform that will improve workflows across the pathology sector.
About the Strategic Partnership
This strategic partnership will leverage L7|ESP® (Enterprise Science Platform), which represents a significant advancement in leading pathology informatics. By combining their respective strengths, Leica Biosystems, a frontrunner in cancer diagnostics, and L7 Informatics, known for its expertise in data unification, are set to create powerful tools for the future.
Addressing Industry Challenges
Pathology departments are facing increasing challenges caused by siloed data systems, growing diagnostic demands, and workforce shortages. These obstacles can slow workflows and prolong critical diagnoses, often due to fragmented data flows. The integration brought about by this partnership will address these challenges effectively.
Enhancing Laboratory Efficiency
By integrating Leica Biosystems' advanced instrumentation with L7|ESP's cutting-edge infrastructure, this partnership aims to automate and streamline processes throughout pathology labs. The focus will be on enhancing reproducibility, operational efficiency, and reducing time-to-diagnosis.
Insights from Leaders
Mark L. Spencer, President and CEO of L7 Informatics, stated, "Our partnership with Leica Biosystems signifies the next stage of digital transformation in diagnostics. The combination of our expertise will pave the way for AI-enabled discovery and diagnosis in the coming decade. We are committed to our customers and, ultimately, to improving patient outcomes."
William Day, Vice President and General Manager of Advanced Staining Instruments at Leica Biosystems, emphasized the company's deep-rooted history in innovation. He noted, "Our partnership with L7 Informatics empowers laboratory professionals by allowing them to prioritize results over workflow management. This is essential for delivering prompt and reliable diagnostics."
Future Developments
Leica Biosystems is progressing with the integration of L7|ESP into its workflow solutions. The commercial availability of products stemming from this partnership is expected soon, with a target date set for early 2026. This readiness will allow labs to implement these advanced tools and significantly upgrade their operational capabilities.
About Leica Biosystems
Leica Biosystems specializes in cancer diagnostics and stands out as a global leader in anatomic and digital pathology solutions. The comprehensive range offered by the company covers every stage of the pathology process—from sample preparation and staining to imaging and reporting. Their mission, aimed at "Advancing Cancer Diagnostics, Improving Lives," drives innovation in partnership with various cancer centers worldwide. Leica Biosystems, a subsidiary of Danaher Corporation, is uniquely positioned within the market.
About L7 Informatics
Founded in 2012 and headquartered in Austin, L7 Informatics is revolutionizing digital transformation in life sciences. Their L7|ESP® platform is designed to unify data while orchestrating workflows and enabling AI operations across multiple environments. By connecting disparate systems, L7 Informatics provides a cohesive scientific platform with extensive API integrations and built-in applications like LIMS, ELN, and Inventory Management.
Frequently Asked Questions
What does the partnership between Leica Biosystems and L7 Informatics entail?
The partnership focuses on creating a unified platform that enhances operational efficiency in pathology through advanced data integration and automation.
What are the primary benefits of this collaboration?
The collaboration aims to streamline processes, improve reproducibility, and accelerate diagnosis times for better cancer diagnostics.
When can we expect products from this partnership?
Commercial product availability is anticipated in early 2026.
How does L7|ESP work to improve lab workflows?
L7|ESP integrates various data systems and automates processes, allowing lab professionals to focus on delivering results more efficiently.
What is the mission of Leica Biosystems?
The mission is to advance cancer diagnostics and improve lives through innovative solutions and partnerships with cancer centers globally.
